Chronic Kidney Disease News and Research

Latest Chronic Kidney Disease News and Research

New AI tool predicts the extent of chronic damage in the kidney

Chronic kidney disease (CKD) is caused by diabetes and hypertension. In 2017, the global prevalence of CKD was 9.1 percent, which is approximately 700 million cases.

24 May 2021

Researchers report promising biotherapeutics for obesity and related medical complications

The research teams at the University of Hong Kong led by Professor Xuechen LI from the Research Division for Chemistry and Department of Chemistry, and Professor Yu WANG from the Department of Pharmacology and Pharmacy, reported a synthetic biotherapeutics with promising anti-tumor, insulin sensitising and hepatoprotective activities in the Journal of the American Chemical Society.

18 May 2021

Sotagliflozin reduces adverse cardiovascular events across patients with diabetes, heart failure

Patients with both diabetes and heart failure who were treated with sotagliflozin, a novel investigational drug for diabetes, for a median of nine to 16 months experienced reductions of 22% to 43% in the risk of death or worsening heart failure compared with similar patients who were treated with a placebo

18 May 2021

Brief pulses of ultrasound delivered to nerves in renal arteries reduce drug-resistant blood pressure

Brief pulses of ultrasound delivered to nerves near the kidney produced a clinically meaningful drop in blood pressure in people whose hypertension did not respond to a triple cocktail of medications, reports a new study led by researchers at Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian.

17 May 2021

Farxiga approved in the US for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes

Approval is the most significant advancement in the treatment of chronic kidney disease in more than 20 years. In DAPA-CKD Phase III trial, Farxiga demonstrated unprecedented reduction in the risk of the composite of worsening of renal function, end-stage kidney disease and cardiovascular or renal death.

From AstraZeneca 14 May 2021

HIV patients are more likely to die from COVID-19 infection

Over the past year, studies have revealed that certain pre-existing conditions, such as cancer, diabetes and high blood pressure, can increase a person's risk of dying from COVID-19.

12 May 2021

Researchers show how low-protein diet during pregnancy can cause kidney problems in babies

Besides being underweight, babies born to women whose diet lacked sufficient protein during pregnancy tend to have kidney problems resulting from alterations that occurred while their organs were forming during the embryonic stage of their development.

5 May 2021

Study: Only half of Americans with a history of heart disease get annual flu shot

People with heart disease are more likely to become seriously ill from the flu and other respiratory illnesses, including the coronavirus.

5 May 2021

Study could pave way for new therapies for kidney disease

Our kidneys are charged with the extraordinary task of filtering about 53 gallons of fluid a day, a process that depends on podocytes, tiny, highly specialized cells in the cluster of blood vessels in the kidney where waste is filtered that are highly vulnerable to damage.

5 May 2021

New enzyme may help curb chronic kidney disease

University of South Australia researchers have identified an enzyme that may help to curb chronic kidney disease, which affects approximately 700 million people worldwide.

4 May 2021

Disparities exist in colorectal cancer screenings, study finds

Patients with one or more health conditions are more likely to be screened for colorectal cancer than those without comorbidities, according to new research in the Journal of Osteopathic Medicine.

3 May 2021

FDA approves new drug for treatment of adults with chronic kidney disease

Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression.

30 Apr 2021

Algorithm interprets data from electronic medical records to diagnose kidney disease

Diagnosing chronic kidney disease, which is often undetected until it causes irreversible damage, may soon become automated with a new algorithm that interprets data from electronic medical records.

29 Apr 2021

Study in Ireland identifies underlying conditions associated with severe COVID-19 outcomes

A national study of 20,000 patients conducted by RCSI University of Medicine and Health Sciences and the HSE Health Protection Surveillance Centre (HPSC) has identified the underlying conditions that are associated with more severe outcomes from COVID-19 in an Irish setting.

27 Apr 2021

People with a higher Omega-3 Index lived longer than others, study shows

A new research paper examining the relationship between the Omega-3 Index and risk for death from any and all causes has been published in Nature Communications.

23 Apr 2021

New study demonstrates the effectiveness of COVID-19 vaccine in specific sub-populations

Several weeks following the publication of the large real-world Covid-19 vaccine effectiveness study by the Clalit Research Institute in Collaboration with Harvard University in the New England Journal of Medicine (NEJM), additional results focusing on vaccine effectiveness in specific sub-populations have now been published.

23 Apr 2021

COVID-19 survivors have increased risk of death for at least six months

As the COVID-19 pandemic has progressed, it has become clear that many survivors - even those who had mild cases - continue to manage a variety of health problems long after the initial infection should have resolved.

23 Apr 2021

Drugs can help prevent progression of cardiac hypertrophy in hemodialysis patients

Patients with chronic kidney dysfunction frequently develop thickening of the heart muscle, so-called left ventricular hypertrophy. This is particularly pronounced in patients who are in the late stage of renal dysfunction, that is to say those requiring renal replacement therapy such as hemodialysis.

22 Apr 2021

Anti-diabetic drug metformin inhibits disease progression in Alport syndrome mouse model

Researchers from Kumamoto University have found that the anti-diabetic drug metformin significantly prolongs the survival of mice in a model that simulates the pathology of non-diabetic chronic kidney disease (ND-CKD) by ameliorating pathological conditions like reduced kidney function, glomerular damage, inflammation and fibrosis.

15 Apr 2021

Series of reviews discuss key issues in chronic kidney disease and bone disorders

Metabolic bone disease is a common complication of chronic kidney disease (CKD) and involves a broad spectrum of disorders of mineral metabolism that result in both skeletal and extra-skeletal consequences.

15 Apr 2021

Chronic Kidney Disease News and Research

Latest Chronic Kidney Disease News and Research

New AI tool predicts the extent of chronic damage in the kidney

Researchers report promising biotherapeutics for obesity and related medical complications

Sotagliflozin reduces adverse cardiovascular events across patients with diabetes, heart failure

Brief pulses of ultrasound delivered to nerves in renal arteries reduce drug-resistant blood pressure

Farxiga approved in the US for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes

HIV patients are more likely to die from COVID-19 infection

Researchers show how low-protein diet during pregnancy can cause kidney problems in babies

Study: Only half of Americans with a history of heart disease get annual flu shot

Study could pave way for new therapies for kidney disease

New enzyme may help curb chronic kidney disease

Disparities exist in colorectal cancer screenings, study finds

FDA approves new drug for treatment of adults with chronic kidney disease

Algorithm interprets data from electronic medical records to diagnose kidney disease

Study in Ireland identifies underlying conditions associated with severe COVID-19 outcomes

People with a higher Omega-3 Index lived longer than others, study shows

New study demonstrates the effectiveness of COVID-19 vaccine in specific sub-populations

COVID-19 survivors have increased risk of death for at least six months

Drugs can help prevent progression of cardiac hypertrophy in hemodialysis patients

Anti-diabetic drug metformin inhibits disease progression in Alport syndrome mouse model

Series of reviews discuss key issues in chronic kidney disease and bone disorders

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Chronic Kidney Disease News and Research

Latest Chronic Kidney Disease News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in